Carvedilol from Japan
Carvedilol, a non-selective beta/alpha-1 blocker with complex aromatic amino-oxygen functionality, qualifies as a cardiovascular drug under HTS 2922.50.1400. It treats congestive heart failure and hypertension by vasodilation and reduced cardiac workload.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%
Import Tips
• Provide polymorphic form characterization (XRPD data) as different forms affect bioavailability
• Ensure DMF Type II filed with FDA; reference DMF number on commercial invoice
• Monitor for FDA import alerts on Chinese/Indian origins due to past quality issues